Navigation Links
ABA Conference in Chicago Provides Litigators First Look at DNA Technology That Can Save Millions in Workers Comp and Toxic Tort Cases
Date:12/5/2007

CHICAGO, Dec. 5 /PRNewswire/ -- Each year, major corporations and their insurance companies pay out hundreds of millions of dollars in litigation settlements and jury awards for mass-tort cases by workers claiming to have been harmed by exposure to chemicals. Now a new DNA technology promises to weed out frivolous claims from the legitimate ones, saving companies and their insurers millions on such payouts and prompting reasonable settlements and resolutions.

Dr. Bruce Gillis, CEO of the genomics research group, The Cytokine Institute (TCI), is presenting a tutorial on the application of DNA lab-based evidence in workers' compensation and civil litigation at the American Bar Association's "National Program on National Trends" TIPS Staff Counsel CLE for 2008.

For the first time, litigators will tour TCI's affiliate laboratories at the University of Illinois College of Medicine at Chicago (UIC), on March 26 and 28, 2008, where they will gain hands-on experience of the new genomics- based technology, msds1(TM). The technology is already being used in some civil courts to weed out baseless lawsuits by identifying on a cellular level if an individual has suffered injury due to a specific chemical or toxic exposure.

By analyzing how 36,000 parameters of an individual's DNA are affected by specific chemicals -- including benzene, chromium, asbestos and formaldehyde -- this technology can determine with 99.9% certainty if a person was injuriously exposed to a particular toxin, thereby offering an objective methodology for providing scientifically-based evidence. Companies facing class-action and mass-tort lawsuits immediately benefit by knowing how chemicals and toxins in their workplace affect human health and the environment.

Sponsored by the ABA, and co-sponsored by the Workers' Injury Law & Advocacy Group, The College of Workers' Compensation Lawyers, The National Conference of the Administrative Law Judiciary, The American College of Occupational and Environmental Medicine (ACOEM), and The American Medical Association (AMA), the conference will be held March 26-28, 2008 at the InterContinental Hotel in Chicago, IL. It will assemble legal experts in Workers' Compensation law, products liability law, toxic tort litigation, employment law, and occupational medicine. For more information visit http://www.abanet.org/tips.

With an M.D. degree from the University of Illinois College of Medicine, a M.P.H. degree from the Harvard University School of Public Health, and medical residencies in Occupational Medicine and Medical Toxicology and in Internal Medicine, Dr. Bruce Gillis brings over 30 years of medical expertise to his position as founder and CEO of The Cytokine Institute.

The Cytokine Institute provides a variety of consulting services in the area of litigation support, risk management, human resources, medical toxicology and healthcare. The organization developed DNA-based technologies, which provide vital information that is germane to Material Safety Data Sheets, the recently enacted REACH protocol and numerous other international, and United States rules and regulations concerning potentially harmful substances.

CONTACT: For more information or an interview with Dr. Gillis and his team, visit http://www.cytokineinstitute.com or contact Leslie Valenza at (202) 258-3223 or lvalenza@levick.com.


'/>"/>
SOURCE The Cytokine Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. AtriCure to Present at Roth Capital Partners 2007 New York Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: